Seema Qaiyumi Frosh is a Orlando, Florida based female rheumatologist who is specialized in Rheumatology. Active license number of Seema Qaiyumi Frosh for Rheumatology is ME120090 in Florida. Seema Qaiyumi Frosh treat joint disease similar to orthopedists but do not perform surgeries. She diagnose and treat diseases of joints, muscle, bones and tendons which includes arthritis, back pain, muscle strains, common athletic injuries and 'collagen' diseases.
Complete Profile:
Seema Qaiyumi Frosh speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Rheumatology
Credentials:
MD
Gender:
Female
Practice Address:
13800 Veterans Way, Orlando, Florida, 32827-7403
Phone:
407-631-1000
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1669635439
NPI Enumeration Date:
02 Jul, 2008
NPI Last Update On:
26 Aug, 2015
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Seema Qaiyumi Frosh are as mentioned below.
License Number
Specialization
State
Status
ME120090
Rheumatologist
Florida
Primary
Student in an Organized Health Care Education/Training Program
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
13800 Veterans Way, Orlando, Florida
Zip:
32827-7403
Phone Number:
407-631-1000
Fax Number:
--
Patients can reach Seema Qaiyumi Frosh at 13800 Veterans Way, Orlando, Florida or can call to book an appointment on 407-631-1000. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 May, 2024.